Triazolam

  • TRADE NAMES: Dumozolam; Halcion (Pfizer); Novo-Triolam; Nu-Triazo; Nuctane; Somese; Somniton; Songar; Trialam
  • INDICATIONS: Insomnia
  • CLASS: Benzodiazepine
  • HALF-LIFE: 1.5–5.5 hours

Our database has 28 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GENITOURINARY
OTIC
OCULAR


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric